Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-31

Clinical Trial Update: Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics [NA]

View source ↗

Summary

Clinical trial update evaluating gastrointestinal transit before and after treatment with a non-selective beta-blocker in patients with liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Non-selective beta-blocker

Snippet

Sponsor: ALDO TORRE DELGADILLO | Conditions: Liver Cirrhosis | NA | Status: UNKNOWN